Metformin Vitabalans

Metformin Hydrochloride, the active ingredient in Metformin Vitabalans, is a biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adult patients by improving blood‑glucose control.

GNH USA supplies Metformin Vitabalans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Vitabalans is a biguanide indicated for disorders of glucose metabolism. - Type 2 diabetes mellitus: improves glycaemic control and reduces HbA1c levels. - Gestational diabetes mellitus: helps achieve target blood‑glucose levels during pregnancy. - Prediabetes (impaired fasting glucose): delays progression to overt diabetes by lowering fasting glucose.

Metformin Vitabalans may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools, especially early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycaemia: when combined with insulin or sulfonylureas. - Vitamin B12 deficiency: long‑term use may lower B12 levels. - Pancreatitis: inflammation of the pancreas.

Metformin Vitabalans requires careful patient assessment before and during therapy. - Renal function monitoring: avoid use in severe renal impairment. - Hepatic function assessment: evaluate liver disease risk. - Lactic acidosis risk: discontinue before radiographic contrast studies. - Elderly dose adjustment: consider lower starting dose. - Concomitant medication review: assess for drugs that may increase metformin levels. - Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin may interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate lactic acidosis. - Cimetidine: increases metformin plasma concentration. - Alcohol excess: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function and potassium. - NSAIDs: may reduce renal perfusion, raising metformin levels. - Warfarin: may require INR monitoring.